CR20130178A - COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0.]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR 2/3 - Google Patents

COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0.]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR 2/3

Info

Publication number
CR20130178A
CR20130178A CR20130178A CR20130178A CR20130178A CR 20130178 A CR20130178 A CR 20130178A CR 20130178 A CR20130178 A CR 20130178A CR 20130178 A CR20130178 A CR 20130178A CR 20130178 A CR20130178 A CR 20130178A
Authority
CR
Costa Rica
Prior art keywords
phenylsulphanylme
mglur
antagonists
hexane
substituted
Prior art date
Application number
CR20130178A
Other languages
English (en)
Inventor
Stephon Cornell Smith
Renhua Li
Charles Howard Mitch
Tatiana Natali Vetman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45099188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20130178(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CR20130178A publication Critical patent/CR20130178A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UN ANTAGONISTA DEL RECEPTOR mGlu2/3 DE LA FÓRMULA, SE DESCRIBEN SUS USOS, Y MÉTODOS PARA SU PREPARACIÓN.-
CR20130178A 2010-11-18 2013-04-24 COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0.]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR 2/3 CR20130178A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41512110P 2010-11-18 2010-11-18
PCT/US2011/060730 WO2012068067A1 (en) 2010-11-18 2011-11-15 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists

Publications (1)

Publication Number Publication Date
CR20130178A true CR20130178A (es) 2013-07-09

Family

ID=45099188

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20130178A CR20130178A (es) 2010-11-18 2013-04-24 COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0.]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR 2/3

Country Status (36)

Country Link
US (1) US8629169B2 (es)
EP (1) EP2640697B1 (es)
JP (1) JP5877847B2 (es)
KR (2) KR20150140876A (es)
CN (1) CN103228625B (es)
AR (1) AR083845A1 (es)
AU (1) AU2011329076B2 (es)
BR (1) BR112013012118A2 (es)
CA (1) CA2818116C (es)
CL (1) CL2013001345A1 (es)
CO (1) CO6761385A2 (es)
CR (1) CR20130178A (es)
DK (1) DK2640697T3 (es)
DO (1) DOP2013000099A (es)
EA (1) EA021724B1 (es)
EC (1) ECSP13012629A (es)
ES (1) ES2650139T3 (es)
GT (1) GT201300126A (es)
HR (1) HRP20171649T1 (es)
HU (1) HUE037457T2 (es)
IL (1) IL225843A (es)
LT (1) LT2640697T (es)
MA (1) MA34663B1 (es)
MX (1) MX339973B (es)
NO (1) NO2640697T3 (es)
NZ (1) NZ609816A (es)
PE (1) PE20140997A1 (es)
PL (1) PL2640697T3 (es)
PT (1) PT2640697T (es)
RS (1) RS56535B1 (es)
SG (1) SG189959A1 (es)
SI (1) SI2640697T1 (es)
TW (1) TWI520935B (es)
UA (1) UA110039C2 (es)
WO (1) WO2012068067A1 (es)
ZA (1) ZA201302918B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2978B1 (en) * 2009-12-21 2016-03-15 ايلي ليلي اند كومباني MGLU2 aids
EP3000814A1 (en) 2014-09-26 2016-03-30 Domain Therapeutics Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
DK3445743T3 (da) 2016-04-18 2021-10-18 Taisho Pharmaceutical Co Ltd Prodrug af aminosyrederivat
JP2020506895A (ja) 2017-01-17 2020-03-05 ボード オブ レジェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System インドールアミン２，３−ジオキシゲナーゼおよび／またはトリプトファンジオキシゲナーゼの阻害剤として有用な化合物
US11046649B2 (en) 2018-07-17 2021-06-29 Board Of Regents, The University Of Texas System Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0669928B2 (ja) 1987-10-06 1994-09-07 宇部興産株式会社 光重合性歯科材料
JP2589812B2 (ja) 1989-07-05 1997-03-12 松下電器産業株式会社 スチームアイロン
EA000894B1 (ru) * 1995-11-16 2000-06-26 Эли Лилли Энд Компани Замещенные бициклогексанкарбоновые кислоты и их производные в качестве антагонистов рецептора возбуждающих аминокислот, способ их получения и применение
ZA969485B (en) 1995-11-16 1998-05-12 Lilly Co Eli Excitatory amino acid receptor antagonists.
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
EP1064256B1 (en) * 1998-03-17 2004-08-04 Pfizer Products Inc. Bicyclo [2.2.1] heptanes and related compounds
GB9815542D0 (en) 1998-07-17 1998-09-16 Lilly Co Eli Bicyclohexane derivatives
CH694053A5 (de) 1998-09-03 2004-06-30 Hoffmann La Roche Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
WO2002068380A1 (en) * 2001-02-22 2002-09-06 Eli Lilly And Company Synthetic excitatory amino acids
AU2002359923B2 (en) 2001-12-27 2007-12-20 Taisho Pharmaceutical Co., Ltd. 6-fluorobicyclo[3.1.0]hexane derivatives
PT1517915E (pt) * 2002-06-11 2009-04-09 Lilly Co Eli Pró-drogas de amino ácidos de excitação
NZ580554A (en) * 2003-06-26 2011-01-28 Taisho Pharmaceutical Co Ltd 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative
JP2007063129A (ja) 2003-06-26 2007-03-15 Taisho Pharmaceut Co Ltd ２−アミノ−３−アルコキシビシクロ［３．１．０］ヘキサン誘導体
WO2005000790A1 (ja) * 2003-06-26 2005-01-06 Taisho Pharmaceutical Co., Ltd. ２－アミノビシクロ[３．１．０]ヘキサン－２，６－ジカルボン酸誘導体
JO2978B1 (en) * 2009-12-21 2016-03-15 ايلي ليلي اند كومباني MGLU2 aids

Also Published As

Publication number Publication date
CO6761385A2 (es) 2013-09-30
MA34663B1 (fr) 2013-11-02
DOP2013000099A (es) 2013-08-15
NO2640697T3 (es) 2018-02-17
SG189959A1 (en) 2013-06-28
WO2012068067A1 (en) 2012-05-24
TW201307271A (zh) 2013-02-16
TWI520935B (zh) 2016-02-11
SI2640697T1 (sl) 2017-11-30
KR20130101094A (ko) 2013-09-12
EA201390498A1 (ru) 2013-07-30
ZA201302918B (en) 2014-10-29
AU2011329076B2 (en) 2015-03-12
GT201300126A (es) 2014-02-27
IL225843A (en) 2015-05-31
JP2014505664A (ja) 2014-03-06
CA2818116A1 (en) 2012-05-24
RS56535B1 (sr) 2018-02-28
MX339973B (es) 2016-06-20
UA110039C2 (xx) 2015-11-10
CN103228625B (zh) 2014-12-03
AU2011329076A1 (en) 2013-05-02
CA2818116C (en) 2016-04-05
NZ609816A (en) 2014-12-24
HUE037457T2 (hu) 2018-08-28
EA021724B1 (ru) 2015-08-31
JP5877847B2 (ja) 2016-03-08
PT2640697T (pt) 2017-12-11
PL2640697T3 (pl) 2018-02-28
PE20140997A1 (es) 2014-08-25
EP2640697A1 (en) 2013-09-25
US8629169B2 (en) 2014-01-14
KR20150140876A (ko) 2015-12-16
LT2640697T (lt) 2018-01-10
HRP20171649T1 (hr) 2017-12-15
CL2013001345A1 (es) 2013-11-15
ES2650139T3 (es) 2018-01-17
CN103228625A (zh) 2013-07-31
AR083845A1 (es) 2013-03-27
IL225843A0 (en) 2013-06-27
US20120129902A1 (en) 2012-05-24
MX2013005622A (es) 2013-07-05
EP2640697B1 (en) 2017-09-20
ECSP13012629A (es) 2013-07-31
DK2640697T3 (en) 2017-10-23
BR112013012118A2 (pt) 2016-09-27

Similar Documents

Publication Publication Date Title
DOP2012000135A (es) Compuestos de espiropiperidina como antagonistas del receptor orl-1
GB201017345D0 (en) Receptor antagonists
GT201500138A (es) Novedososo derivados de bencimidazol como antagonistas de ep4
CU24094B1 (es) Anticuerpos para el receptor 3 del factor de crecimiento epidérmico(her3)
ECSP12012221A (es) Anticuerpos anti-cd40
UY34352A (es) 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante
UY34467A (es) Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
MX2014010849A (es) Formas solidas de un inhibidor de cinasa del receptor del factor de crecimiento epidermico.
CR20140306A (es) Fluormetil -5,6-dihidro-4h-[1,3] oxazinas
HUE048509T2 (hu) Vezeték nélküli adások dinamikus tiltása átlapolódó alapszolgáltatás-készletekkel
CR20130178A (es) COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0.]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR 2/3
BR112013028511A2 (pt) receptor de sinais de radiofrequência
CO6470820A2 (es) Espiro-epóxidos como productos intermedios
HK1178902A1 (en) Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor b1
ES2636441T8 (es) Un procedimiento novedoso para la síntesis de polifenoles
HK1207855A1 (en) Substituted carbamate compounds and their use as transient receptor potential (trp) channel antagonists (trp)
GT201200328A (es) Intermedios de agomelatina y método de preparación de éstos
CL2015000038A1 (es) Métodos para preparar triazolopiridinas sustituidas y compuestos intermediarios.
BR112013012384A2 (pt) compostos 3-benzilóóxi-biciclo[3.1.0]hexano 4-substituídos como antagonistas receptores de mglu2 e mglu3
EP3046923A4 (en) Formulations for cgrp receptor antagonists
MX2013000539A (es) Nuevas formulaciones de analogos 14-epi de la vitamina d.
UY34734A (es) Un antagonista del receptor h3 para uso en el tratamiento de la enfermedad de alzheimer.
HK1208028A1 (en) Novel acetamide derivatives as trp channel antagonists trp
TN2013000209A1 (en) 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists
UA54879U (ru) Применение антагониста рецепторов интерлейкина-1 как средства антиоксидантного действия